IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

Ann: Positive preliminary data from IHL-675A Ph 1 trial, page-23

  1. tonymcm
    59 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    13/10/22
    17:08
    Post #: 64185247
    Hi FB. I think from memory this study was conducted in healthy adults so not possible to report any efficacy data. I would be interested in some of the pharmacokinetic data as that would give insight into things like liver clearance impacting bioavailability etc.
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.